127 related articles for article (PubMed ID: 36524482)
1. Reply Letter - to Urso et al "Comment on: Comparative dissolution profiles of two anti-emetic delayed release dosage forms of doxylamine and pyridoxine: Xonvea® tablets vs. Cariban® capsules".
Alcocer C; Rom E; Regidor PA
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8635-8636. PubMed ID: 36524482
[No Abstract] [Full Text] [Related]
2. Comparative dissolution profiles of two anti-emetic delayed release dosage forms of doxylamine and pyridoxine: Xonvea® tablets vs. Cariban® capsules.
Alcocer C; Iraola M; Rom E; Hoarau D; Gergic E; Perez de la Cruz MA; Regidor PA
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4420-4430. PubMed ID: 35776043
[TBL] [Abstract][Full Text] [Related]
3. Comment on: Comparative dissolution profiles of two anti-emetic delayed-release dosage forms of doxylamine and pyridoxine: Xonvea® tablets vs. Cariban® capsules.
Urso K; Saz-Leal P; Zamorano Dominguez L; Mangrella M
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8206-8208. PubMed ID: 36459003
[No Abstract] [Full Text] [Related]
4. Bioavailability of Cariban
Saz-Leal P; Zamorano-Domínguez L; Frías J; Guerra P; Saura-Valls M; Roca-Juanes R; Nebot-Troyano J; García-Aguilar E; Vilchez T; Urso K
Drugs R D; 2023 Jun; 23(2):185-195. PubMed ID: 37318714
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy.
Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I
BMC Pregnancy Childbirth; 2016 Nov; 16(1):371. PubMed ID: 27881103
[TBL] [Abstract][Full Text] [Related]
6. Systemic bioavailability and pharmacokinetics of the doxylamine-pyridoxine delayed-release combination (Diclectin).
Gill SK; Garcia-Bournissen F; Koren G
Ther Drug Monit; 2011 Feb; 33(1):115-9. PubMed ID: 21079545
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate-pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy.
Koren G; Vranderick M; Gill SK; Macleod S
J Clin Pharmacol; 2013 Dec; 53(12):1268-76. PubMed ID: 24123059
[TBL] [Abstract][Full Text] [Related]
8. The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.
Madjunkova S; Maltepe C; Koren G
Paediatr Drugs; 2014 Jun; 16(3):199-211. PubMed ID: 24574047
[TBL] [Abstract][Full Text] [Related]
9. Chemical cross-linking: A feasible approach to prolong doxylamine/pyridoxine release from spray-dried chitosan microspheres.
Katsarov P; Pilicheva B; Uzunova Y; Gergov G; Kassarova M
Eur J Pharm Sci; 2018 Oct; 123():387-394. PubMed ID: 30077710
[TBL] [Abstract][Full Text] [Related]
10. The return to the USA of doxylamine-pyridoxine delayed release combination (Diclegis®) for morning sickness--a new morning for American women.
Koren G
J Popul Ther Clin Pharmacol; 2013; 20(2):e161-2. PubMed ID: 23863487
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic comparison of a delayed-release combination of doxylamine succinate and pyridoxine hydrocholoride (Diclectin) and oral solutions of these drugs in healthy women of childbearing age.
Nulman I; Koren G
Can J Clin Pharmacol; 2009; 16(3):e400-6. PubMed ID: 19923636
[TBL] [Abstract][Full Text] [Related]
12. Comparing the pharmacokinetics of doxylamine/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy.
Matok I; Clark S; Caritis S; Miodovnik M; Umans J; Hankins G; Koren G
J Clin Pharmacol; 2013 Mar; 53(3):334-8. PubMed ID: 23444286
[TBL] [Abstract][Full Text] [Related]
13. In vitro analytical dissolution profiling of antiemetic delayed release tablets in two different dissolution media: Validated spectrophotometric methods versus reported HPLC.
Eltanany BM; Abd El-Hadi HR; Zaazaa HE; Eissa MS
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Feb; 246():119013. PubMed ID: 33049467
[TBL] [Abstract][Full Text] [Related]
14. Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs.
Matok I; Clark S; Caritis S; Miodovnik M; Umans JG; Hankins G; Mattison DR; Koren G
J Clin Pharmacol; 2014 Dec; 54(12):1429-33. PubMed ID: 25052410
[TBL] [Abstract][Full Text] [Related]
15. Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy.
Costantine MM; Matok I; Chiossi G; Clark S; Miodovnik M; Umans JG; Caritis S; Hankins GD; Koren G
Ther Drug Monit; 2012 Oct; 34(5):569-73. PubMed ID: 22972538
[TBL] [Abstract][Full Text] [Related]
16. Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy?
Persaud N; Chin J; Walker M
J Obstet Gynaecol Can; 2014 Apr; 36(4):343-348. PubMed ID: 24798673
[TBL] [Abstract][Full Text] [Related]
17. Diclegis for nausea and vomiting of pregnancy.
Med Lett Drugs Ther; 2013 Aug; 55(1422):61-2. PubMed ID: 23917384
[No Abstract] [Full Text] [Related]
18. A new pharmacologic treatment for nausea and vomiting of pregnancy.
Fantasia HC
Nurs Womens Health; 2014; 18(1):73-77. PubMed ID: 24548499
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
[TBL] [Abstract][Full Text] [Related]
20. Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study.
Pope E; Maltepe C; Koren G
J Clin Pharmacol; 2015 Jul; 55(7):809-14. PubMed ID: 25663469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
